China Cord Blood (CO) and Select Medical (SEM) Head-To-Head Comparison
Select Medical (NYSE: SEM) and China Cord Blood (NYSE:CO) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership.
Insider & Institutional Ownership
77.9% of Select Medical shares are owned by institutional investors. Comparatively, 9.1% of China Cord Blood shares are owned by institutional investors. 19.9% of Select Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This is a summary of recent recommendations and price targets for Select Medical and China Cord Blood, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|China Cord Blood||0||0||0||0||N/A|
Select Medical presently has a consensus target price of $19.50, suggesting a potential upside of 8.94%. Given Select Medical’s higher possible upside, research analysts clearly believe Select Medical is more favorable than China Cord Blood.
Valuation and Earnings
This table compares Select Medical and China Cord Blood’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Select Medical||$4.29 billion||0.56||$115.41 million||$0.72||24.86|
|China Cord Blood||$110.41 million||10.09||$18.33 million||$0.36||25.67|
Select Medical has higher revenue and earnings than China Cord Blood. Select Medical is trading at a lower price-to-earnings ratio than China Cord Blood, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Select Medical has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500. Comparatively, China Cord Blood has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500.
This table compares Select Medical and China Cord Blood’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|China Cord Blood||26.79%||9.68%||4.36%|
Select Medical beats China Cord Blood on 9 of the 13 factors compared between the two stocks.
Select Medical Company Profile
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. The Concentra segment consists of medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics (CBOCs) that deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. As of December 31, 2016, the Company had operations in 46 states and the District of Columbia.
China Cord Blood Company Profile
China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.